Sector consensus Gilead Sciences, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 19:23:11 13/09/2024 BST			5-day change	1st Jan Change
82.52 ^USD	+0.16%		+4.67%	+1.71%

01:00pm	Marengo Therapeutics, Inc. Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Invikafusp alfa and Trodelvy in Both Metastatic TNBC and Metastatic HR+/HER2- Breast Cancers	CI
09-12	Gilead Sciences Says Twice-Yearly HIV Treatment Lenacapavir Reduces Infections by 96%	MT

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
GILEAD SCIENCES, INC.	83.54	+0.46%	27
ELI LILLY AND COMPANY	986.82	+5.54%	25
NOVO NORDISK A/S	967.54	+5.83%	26
JOHNSON & JOHNSON	170.67	+3.66%	22
ABBVIE INC.	196.30	+1.18%	27
MERCK & CO., INC.	139.03	+20.63%	26
ROCHE HOLDING AG	296.42	+12.71%	19
ASTRAZENECA PLC	183.99	+16.78%	20
NOVARTIS AG	116.54	+1.06%	20
AMGEN INC.	324.71	-1.62%	24
PFIZER, INC.	33.23	+13.97%	22
SANOFI	112.17	+9.12%	22
BRISTOL-MYERS SQUIBB COMPANY	53.34	+10.57%	21
GSK PLC	19.68	+20.11%	21
CHUGAI PHARMACEUTICAL CO., LTD	6,663.33	-2.47%	15
DAIICHI SANKYO CO., LTD.	6,531.25	+28.29%	16
TAKEDA PHARMACEUTICAL COMPANY LIMITED	4,768.83	+12.77%	18
HALEON PLC	3.842	-0.83%	17
JIANGSU HENGRUI MEDICINE CO., LTD.	58.20	+29.41%	15
Average	1,142.6	+9.85%	21
Weighted average by Cap.	711.1	+7.80%	23